NPPB and atrial fibrillation: Using the IMPRESS-AF data, the study the hypothesis that spironolactone reduces monocyte counts and monocyte expression of receptors involved in inflammation and that these monocyte characteristics are associated with exercise tolerance, diastolic dysfunction and BNP levels in patients with AF.